Aflac Incorporated (NYSE:AFL) Shares Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp increased its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 19.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,075 shares of the financial services provider's stock after acquiring an additional 3,830 shares during the quarter. OMERS ADMINISTRATION Corp's holdings in Aflac were worth $2,387,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Roxbury Financial LLC purchased a new stake in shares of Aflac in the 4th quarter worth approximately $948,000. Willis Investment Counsel lifted its holdings in Aflac by 1.2% during the fourth quarter. Willis Investment Counsel now owns 273,466 shares of the financial services provider's stock worth $28,287,000 after buying an additional 3,357 shares during the period. Board of the Pension Protection Fund bought a new stake in Aflac during the 4th quarter valued at $1,014,000. Barclays PLC boosted its position in Aflac by 10.1% during the 3rd quarter. Barclays PLC now owns 1,391,127 shares of the financial services provider's stock valued at $155,529,000 after acquiring an additional 127,911 shares in the last quarter. Finally, Integrated Investment Consultants LLC increased its holdings in shares of Aflac by 71.5% in the 4th quarter. Integrated Investment Consultants LLC now owns 41,668 shares of the financial services provider's stock valued at $4,310,000 after acquiring an additional 17,375 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on AFL. JPMorgan Chase & Co. raised their price objective on Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research report on Wednesday, April 2nd. UBS Group raised their price target on shares of Aflac from $109.00 to $114.00 and gave the company a "neutral" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods lifted their price objective on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research report on Wednesday, May 7th. Morgan Stanley decreased their target price on shares of Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Finally, BMO Capital Markets assumed coverage on shares of Aflac in a report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price target on the stock. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $104.21.

Insider Buying and Selling

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This trade represents a 37.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 31,802 shares of company stock worth $3,411,877. 0.90% of the stock is owned by company insiders.

Aflac Stock Performance

Shares of AFL traded up $1.18 during trading hours on Friday, reaching $106.96. 3,427,209 shares of the company traded hands, compared to its average volume of 2,113,342. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The business has a fifty day moving average price of $107.00 and a 200-day moving average price of $106.46. Aflac Incorporated has a 12-month low of $86.46 and a 12-month high of $115.50. The stock has a market capitalization of $57.83 billion, a P/E ratio of 11.14, a P/E/G ratio of 3.24 and a beta of 0.84.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The firm had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a net margin of 28.76% and a return on equity of 16.20%. The firm's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.66 EPS. Equities analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 2nd. Investors of record on Wednesday, May 21st will be given a $0.58 dividend. The ex-dividend date of this dividend is Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a yield of 2.17%. Aflac's dividend payout ratio is currently 36.25%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.